Spectrum Pharmaceuticals, Inc. to Present at the 22nd Annual Roth Capital Markets Growth Conference on Monday, March 15

IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, announced today that an overview of the Company’s business strategy will be given at the 22nd Annual ROTH Capital Markets Conference on Monday, March 15, 2010, at 8:00 am Pacific Time. The conference is being held at the Ritz-Carlton Hotel in Laguna Niguel, California.

MORE ON THIS TOPIC